Enhancement of corneal endothelium wound healing by Rho-associated kinase (ROCK) inhibitor eye drops

British Journal of Ophthalmology

Volumn 95, Issue 7, 2011, Pages 1006-1009

  Okumura, Naoki ^a   Koizumi, Noriko ^b   Ueno, Morio ^a   Sakamoto, Yuji ^b   Takahashi, Hiroaki ^b   Hirata, Kana ^b   Torii, Ryuzo ^c   Hamuro, Junji ^a   Kinoshita, Shigeru ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b DOSHISHA UNIVERSITY   (Japan)

^c SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; EYE DROPS; RHO KINASE;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORNEA ENDOTHELIUM; CORNEAL ENDOTHELIAL CELL LOSS; DRUG DETERMINATION; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG SCREENING; ENZYME INHIBITION; IN VITRO STUDY; IN VIVO STUDY; MACACA; NONHUMAN; PRIORITY JOURNAL; RABBIT; SLIT LAMP; WOUND HEALING;

AMIDES; ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; ENDOTHELIUM, CORNEAL; EPITHELIAL CELLS; MACACA FASCICULARIS; OPHTHALMIC SOLUTIONS; PYRIDINES; RABBITS; RHO-ASSOCIATED KINASES; WOUND HEALING;

EID: 79959334438     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjo.2010.194571     Document Type: Article

References (24)

1. Darlington JK, Adrean SD, Schwab IR. Trends of penetrating keratoplasty in the United States from 1980 to 2004. Ophthalmology 2006;113:2171-5.
2. Ishino Y, Sano Y, Nakamura T, et al. Amniotic membrane as a carrier for cultivated human corneal endothelial cell transplantation. Invest Ophthalmol Vis Sci 2004;45:800-6. (Pubitemid 38868373)
3. Mimura T, Yamagami S, Yokoo S, et al. Sphere therapy for corneal endothelium deficiency in a rabbit model. Invest Ophthalmol Vis Sci 2005;46:3128-35. (Pubitemid 44264297)
4. Koizumi N, Sakamoto Y, Okumura N, et al. Cultivated corneal endothelial cell sheet transplantation in a primate model. Invest Ophthalmol Vis Sci 2007;48:4519-26. (Pubitemid 351260967)
5. Koizumi N, Sakamoto Y, Okumura N, et al. Cultivated corneal endothelial transplantation in a primate: possible future clinical application in corneal endothelial regenerative medicine. Cornea 2008;27(Suppl 1):S48-55.
6. Olson MF, Ashworth A, Hall A. An essential role for Rho, Rac, and Cdc42 GTPases in cell cycle progression through G1. Science 1995;269:1270-2.
7. Hall A. Rho GTPases and the actin cytoskeleton. Science 1998;279:509-14.
8. Riento K, Ridley AJ. Rocks: multifunctional kinases in cell behaviour. Nat Rev Mol Cell Biol 2003;4:446-56. (Pubitemid 36648590)
9. Coleman ML, Marshall CJ, Olson MF. RAS and RHO GTPases in G1-phase cell-cycle regulation. Nat Rev Mol Cell Biol 2004;5:355-66. (Pubitemid 38579473)
10. Okumura N, Ueno M, Koizumi N, et al. Enhancement on primate corneal endothelial cell survival in vitro by a ROCK inhibitor. Invest Ophthalmol Vis Sci 2009;50:3680-7.
11. Joyce NC, Meklir B, Joyce SJ, et al. Cell cycle protein expression and proliferative status in human corneal cells. Invest Ophthalmol Vis Sci 1996;37:645-55. (Pubitemid 26077685)
12. Murphy C, Alvarado J, Juster R, et al. Prenatal and postnatal cellularity of the human corneal endothelium. A quantitative histologic study. Invest Ophthalmol Vis Sci 1984;25:312-22. (Pubitemid 14164779)
13. Miyata K, Drake J, Osakabe Y, et al. Effect of donor age on morphologic variation of cultured human corneal endothelial cells. Cornea 2001;20:59-63. (Pubitemid 32038157)
14. Zhu C, Joyce NC. Proliferative response of corneal endothelial cells from young and older donors. Invest Ophthalmol Vis Sci 2004;45:1743-51. (Pubitemid 38868967)
15. Liao JK, Seto M, Noma K. Rho kinase (ROCK) inhibitors. J Cardiovasc Pharmacol 2007;50:17-24. (Pubitemid 47220442)
16. Yoshioka K, Nakamori S, Itoh K. Overexpression of small GTP-binding protein RhoA promotes invasion of tumor cells. Cancer Res 1999;59:2004-10. (Pubitemid 29186178)
17. Itoh K, Yoshioka K, Akedo H, et al. An essential part for Rho-associated kinase in the transcellular invasion of tumor cells. Nat Med 1999;5:221-5. (Pubitemid 29068531)
18. Koga T, Awai M, Tsutsui J, et al. Rho-associated protein kinase inhibitor, Y-27632, induces alterations in adhesion, contraction and motility in cultured human trabecular meshwork cells. Exp Eye Res 2006;82:362-70. (Pubitemid 43138949)
19. Yin J, Yu FS. Rho kinases regulate corneal epithelial wound healing. Am J Physiol Cell Physiol 2008;295:C378-87.
20. Olson MF. Applications for ROCK kinase inhibition. Curr Opin Cell Biol 2008;20:242-8.
21. Van Horn DL, Sendele DD, Seideman S, et al. Regenerative capacity of the corneal endothelium in rabbit and cat. Invest Ophthalmol Vis Sci 1977;16:597-613. (Pubitemid 8154279)
22. Van Horn DL, Hyndiuk RA. Endothelial wound repair in primate cornea. Exp Eye Res 1975;21:113-24.
23. Tokushige H, Inatani M, Nemoto S, et al. Effects of topical administration of y-39983, a selective rho-associated protein kinase inhibitor, on ocular tissues in rabbits and monkeys. Invest Ophthalmol Vis Sci 2007;48:3216-22. (Pubitemid 351261166)
24. Chen J, Guerriero E, Lathrop K, et al. Rho/ROCK signaling in regulation of corneal epithelial cell cycle progression. Invest Ophthalmol Vis Sci 2008;49:175-83.